Keybanc Maintains Overweight on Regal Rexnord, Raises Price Target to $200
Keybanc analyst Jeffrey Hammond maintains Regal Rexnord (NYSE:RRX) with a Overweight and raises the price target from $185 to $200.
Earnings Scheduled For November 1, 2021
Companies Reporting Before The Bell
• ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter.